---
figid: PMC11355432__marinedrugs-22-00337-g005
pmcid: PMC11355432
image_filename: PMC11355432__marinedrugs-22-00337-g005.jpg
figure_link: /pmc/articles/PMC11355432/figure/F5/
number: Figure 5
figure_title: The effect of CPE administration on the CKD-induced suppression of the
  Mas1 (A)-p(Ser-473)-Akt1 (B)-p(Ser-1177)-eNOS (C) signaling pathway as well as eNOS
  (D) and the p(Ser-1177)-eNOS/eNOS ratio (E).
caption: The effect of CPE administration on the CKD-induced suppression of the Mas1
  (A)-p(Ser-473)-Akt1 (B)-p(Ser-1177)-eNOS (C) signaling pathway as well as eNOS (D)
  and the p(Ser-1177)-eNOS/eNOS ratio (E). (F) The blot of protein expression in the
  kidney of NFx rats. The values represent mean ± SEM. (*) p < 0.05 compared to the
  sham + vehicle. (**) p < 0.05 compared to the NFx + vehicle. Two-way ANOVA and SNK
  post hoc test
article_title: C-Phycoerythrin Prevents Chronic Kidney Disease-Induced Systemic Arterial
  Hypertension, Avoiding Oxidative Stress and Vascular Dysfunction in Remanent Functional
  Kidney
citation: Oscar Iván Florencio-Santiago, et al. Mar Drugs. 2024 Aug;22(8).
year: '2024'
pub_date: 2024-8-
epub_date: 2024-7-25
doi: 10.3390/md22080337
journal_title: Marine Drugs
journa_nlm_ta: Mar Drugs
publisher_name: MDPI
keywords:
- C-phycoerythrin
- phycobiliprotein
- Phormidium persicinum
- 5/6 nephrectomy
- chronic kidney disease
- oxidative stress
- nephroprotection
- antihypertensive
- vascular dysfunction
---
